Allogeneic bone marrow and peripheral stem cell transplantation from a haplo-identical mother and CD34 positive selection for CML

Bone Marrow Transplantation

Volumn 18, Issue 2, 1996, Pages 449-452

  Kato, K ^a   Kojima, S ^a   Kondo, M ^a   Inaba, J ^a   Matsuyama, T ^a  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

Allogeneic BMT and PBSCT; CD34 positive selection; CML; Donor lymphocyte transfusion

Indexed keywords

ALPHA INTERFERON; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; HYDROXYUREA; THIOTEPA; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLAST CELL CRISIS; CASE REPORT; CELL SELECTION; CHRONIC MYELOID LEUKEMIA; DEATH; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFUSION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; STEM CELL TRANSPLANTATION;

ANIMALS; ANTIGENS, CD34; BONE MARROW TRANSPLANTATION; CHILD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE TRANSFUSION; MALE; RABBITS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029788646     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Apperley JF, Mauro FR, Goldman JM et al. Bone marrow transplantation for chronic myeloid leukemia in first chronic phase: importance of a graft-versus-leukemia effect. Br J Haematol 1988; 69: 239-245.
2. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
3. + cells from human bone marrow, cord blood, and mobilized peripheral blood. J Hematother 1993; 2: 333-338.
4. + blood cells. Blood 1995; 86: 2500-2508.
5. Bender JG, To LB, Williams S, Schwartsberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1: 329-341.
6. Lane TA, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275-282.
7. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
8. Verdonck LF, de Gast GC, van Heugten HG, Dekker AW. A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood 1990; 75: 776-780.
9. Löwenberg B, Wagemaker G, van Bekkum DW et al. Graft-versus-host disease following transplantation of 'one log' versus 'two log' T lymphocyte-depleted bone marrow from HLA-identical donors. Bone Marrow Transplant 1986; 1: 133-140.
10. Kolb HJ, Mittermüller J, Clemm Ch et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
11. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
12. Flowers MED, Sullivan KM, Martin P et al. G-CSF stimulated donor peripheral blood infusion(s) as immunotherapy in patients with hematologic malignancies relapsing after allogeneic transplantation. Blood 1995; 86 (Suppl. 1): 564a.
13. van Rhee F, Lin F, Cullis JO et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 1994; 83: 3377-3383.
14. + selected stem cell transplants in patients with advanced leukemia from 3 loci mismatched family donors. Blood 1995; 86 (Suppl. 1): 937a.
15. Nademanee A, Schmidt GM, Parker P et al. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Blood 1995; 86: 1228-1234.
16. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443-447.